SPL Set ID: e2a8c9f9-5f6a-4496-8fd6-2439e564db4f
1 drug(s) with this SPL Set ID
Ranolazine extended-release tablets are available as a film-coated, non-scored, extended-release tablet for oral administration. Ranolazine is a racemic mixture, chemically described as as 1-piperazineacetamide, N -(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-. It has an empirical formula of C 24 H 33 N 3 O 4 , a molecular weight of 427.54 g/mole, and the following structural formula: Ranolazine is a white to off-white crystalline powder. Ranolazine is soluble in dichloromethane and methanol. Ranolazine extended-release tablets contain 500 mg or 1000 mg of ranolazine and the following inactive ingredients: hypromellose, magnesium stearate, methacrylic acid and ethyl acrylate copolymer, microcrystalline cellulose, polysorbate 80, sodium hydroxide and sodium lauryl sulfate. The film coating contains ferrosoferric oxide (1000 mg only), iron oxide red (1000 mg only), iron oxide yellow (1000 mg only), polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide. molecular structure